Olson Clinical Trial #3
CHP 894 (IRB 08‐005659, NCT01050855) Reduced Intensity Conditioning (RIC) Regimen for Patients with Non‐Malignant Disorders
Type: Institutional Prospective Clinical Trial (Olson PI)
Description: This is a Phase II pilot study to evaluate engraftment and toxicity of patients with non-malignant diseases using a reduced intensity conditioning regimen in the setting of allogeneic transplant for non-malignant diseases. Bone Marrow or cord blood will be acceptable as a stem cell source.